Pharmaceutical Commerce
DECEMBER 23, 2024
Jon Hamrick, partner, Curatio Scientia Advisors, discusses upcoming industry challenges at this year's Trade & Channel Strategies Conference in Philadelphia.
Pharmaceutical Technology
DECEMBER 23, 2024
Lillys Zepbound has become the first prescription medicine approved to treat adults with moderate to severe obstructive sleep apnoea (OSA) and obesity.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
AuroBlog - Aurous Healthcare Clinical Trials blog
DECEMBER 23, 2024
(Runstudio/Photodisc/Getty Images) If you find yourself sniffling at the merest hint of an irritant, you likely have a different set of microbes calling your nostrils home than everyone else. An international team of researchers has found a unique assortment of fungi up the noses of people who suffer from hayfever and asthma.
Pharmaceutical Technology
DECEMBER 23, 2024
Pfizer has gained accelerated approval from the US FDA for BRAFTOVI in conjunction with cetuximab and mFOLFOX6 for treating mCRC.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharma Mirror
DECEMBER 23, 2024
Have you ever wondered how life-saving treatments for cancer, Alzheimers, or chronic diseases come to life? Clinical trials are the foundation of medical innovation, paving the way for groundbreaking therapies. Yet for many, the idea of joining a trial can feel intimidating or unclear. Experts are here to demystify the clinical trial process, with Dr.
Pharmaceutical Technology
DECEMBER 23, 2024
GlobalData analysis sees Lilly's investment in UK life sciences as an opportunity to drive economic growth whilst improving public health.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Pharmaceutical Technology
DECEMBER 23, 2024
Vertex has won two cystic fibrosis approvals from the FDA, but the agency included high-level safety warnings.
Fierce Pharma
DECEMBER 23, 2024
The FDA has approved Vertexs Alyftrek, a once-daily triple combination for the treatment of cystic fibrosis. But analysts have different views on how the switch from Vertex's twice-daily Trikafta will play out.
Pharmaceutical Technology
DECEMBER 23, 2024
Though still below boom levels seen a few years ago, 2024 compares favourably to 2023, and signs suggest that growth will continue into 2025.
XTalks
DECEMBER 23, 2024
The International Day of Epidemic Preparedness, observed annually on December 27 , underscores the necessity of global collaboration to address epidemic threats. Proclaimed by the United Nations (UN) in 2020, this day honors lessons from past crises like COVID-19, emphasizing the importance of readiness in safeguarding lives and economies. A recent World Health Organization (WHO) report revealed a troubling decline in health spending , threatening epidemic resilience by weakening critical system
Pharmaceutical Technology
DECEMBER 23, 2024
SK bioscience and Sanofi have expanded their agreement to jointly develop pneumococcal conjugate vaccines (PCVs).
Fierce Pharma
DECEMBER 23, 2024
The FDA approved Novo Nordisk's tissue factor pathway inhibitor (TFPI) antagonist concizumab as a once-a-day treatment to prevent or curb the frequency of bleeding episodes in patients ages 12 and older who have hemophilia A or B with inhibitors. The green light follows a rejection in 2023 and a trial pause over safety concerns several years before that.
XTalks
DECEMBER 23, 2024
A new Phase IIb clinical trial, ELEVATE IPF, has delivered promising results for deupirfenidone ( LYT-100 ), an investigational drug being evaluated to slow lung function decline in patients with idiopathic pulmonary fibrosis (IPF). The trial involved 257 participants and tested two doses of deupirfenidone over 26 weeks, with participants taking the drug three times a day (TID).
pharmaphorum
DECEMBER 23, 2024
Stay updated on the latest Good Manufacturing Practices (GMP) and quality compliance standards in the digital era with our comprehensive guide. Learn how to ensure your products meet regulatory requirements.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Drug Patent Watch
DECEMBER 23, 2024
VICTRELIS (boceprevir) Merck sharp dohme Patent: RE43298 Expiration: Dec 22, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.
Pharmaceutical Commerce
DECEMBER 23, 2024
How will supply chains in the space continue to develop?
Velocity Clinical Research
DECEMBER 23, 2024
Rising costs, evolving regulations, and the unstoppable growth of AI are set to shape clinical trials in 2025. How will sites, new tech, promising obesity drugs, and shifting policies affect our industry? Read this article from Paul Evans featured on PharmiWeb: [link] The post 2025 Clinical Trials Outlook: Six Industry Trends to Expect appeared first on Velocity Clinical Research.
Pharmaceutical Commerce
DECEMBER 23, 2024
The latest news for pharma industry insiders.
Fierce Pharma
DECEMBER 23, 2024
For many readers, the topics featured in this years roundup of top stories wont come as much of a surprise. Look no further than our top two stories of the year, and youll see that the GLP-1 craze and Big Pharma layoffs took center stage in 2024.
FDA Law Blog
DECEMBER 23, 2024
By Mark A. Tobolowsky & Frank J. Sasinowski The Winter Solstice, signifying the shortest day of the year, was Saturday, December 21. Although the earliest sunset of the year was actually in early December, this day also marked another premature sunset the beginning of the end of the rare pediatric disease priority review voucher program. As we blogged recently, the program has had scheduled sunset dates from its very beginning, which have been repeatedly extended.
Fierce Pharma
DECEMBER 23, 2024
Bristol Myers Squibb has reported positive results for two phase 3 trials of Sotyktu in adult patients who have psoriatic arthritis. Without revealing figures, BMS said that the POETYK PsA-1 and POETYK PsA-2 studies achieved their respective primary endpoints, as a significantly greater proportion of patients on Sotyktu achieved at least a 20 percent improvement in symptoms compared to those on placebo at Week 16.
AuroBlog - Aurous Healthcare Clinical Trials blog
DECEMBER 23, 2024
The Parliamentary Standing Committee on Chemicals and Fertilisers has recommended to the government to assess the actual staffing requirement of the Central Drugs Standard Control Organisation (CDSCO) since the existing posts are insufficient to meet the country’s regulatory requirements.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Drug Discovery World podcast
DECEMBER 23, 2024
The latest episode of the DDW Highlightspodcast is now available to listen to and watch below. DDWs Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. As we approach the end of 2024, its great to see that investment in drug discovery is still going strong, with an impressive $300 million raised by AI-focused company SandboxAQ and another significant financing by Ottimo Pharma.
Expert insights. Personalized for you.
52 
Let's personalize your content